Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
The podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Credits:
CTV News, Canada’s Chief Public Health Officer Says a Coronavirus Vaccine is ‘Probably’ a Year Away
The trade battle between Canada and the U.S. took a brief break last week as hours before the Trump tariffs were scheduled to take...
The “right to be forgotten” – perhaps better characterized as a right to de-index - has been a hotly debated privacy issue for well...
Stablecoins have increasingly begun to enter the mainstream with previously reticent policy makers, regulators, and financial institutions now shifting toward regulatory frameworks that seem...